Knowledge

Hereditary nonpolyposis colorectal cancer

Source đź“ť

832:(MMR) protein expression in tumours that are associated with Lynch syndrome. While it is not diagnostic of a Lynch syndrome, it can play a role in identifying people who should have germline testing. Two methods of implementation of IHC testing includes age-based testing and universal testing for all people. Currently, there is no widespread agreement regarding which screening method should be used. Age-based testing for IHC has been suggested in part due to cost-benefit analyses, whereas universal testing for all people with colorectal cancer ensures people with Lynch Syndrome are not missed. To address the costs, researchers are trying to predict MSI or IHC directly from the way the tumor looks under the microscope, without doing any molecular testing. 32: 75: 501: 781:. Therefore, families found to have a deleterious mutation in a Lynch syndrome gene should be considered to have Lynch syndrome regardless of the extent of the family history. This also means that the Amsterdam criteria fail to identify many people who are at risk for Lynch syndrome. Improving the criteria for screening is an active area of research, as detailed in the Screening Strategies section of this article. 785:
new generation, without inheriting the gene. These people are often only identified after developing an early-life colon cancer. Parents with HNPCC have a 50% chance of passing the genetic mutation on to each child. It is also important to note, that deleterious mutation in one of MMR genes alone is not sufficient to cause cancer, but that rather further mutations in other tumour suppressor genes need to occur.
1201:, characterized the syndrome in 1966. In his earlier work, he described the disease entity as "cancer family syndrome." The term "Lynch syndrome" was coined in 1984 by other authors; Lynch named the condition HNPCC in 1985. Since then the two terms have been used interchangeably, until later advances in the understanding of the genetics of the disease led to the term HNPCC falling out of favor. 784:
Most people with Lynch syndrome inherit the condition from a parent. However, due to incomplete penetrance, variable age of cancer diagnosis, cancer risk reduction, or early death, not all people with an Lynch syndrome gene mutation have a parent who had cancer. Some people develop HNPCC de-novo in a
1212:
are met but there is no known DNA mismatch repair defect. The putative "type X" families appear to have a lower overall incidence of cancer and lower risk for non-colorectal cancers than families with documented DNA mismatch repair deficiency. About 35% of people who meet Amsterdam criteria do not
1055:
The Bethesda criteria were developed in 1997 and later updated in 2004 by the National Cancer Institute to identify persons requiring further testing for Lynch syndrome through MSI. In contrast to the Amsterdam Criteria, the Revised Bethesda Guidelines use pathological data in addition to clinical
574:
The impairment of either gene for the protein dimer impairs the protein function. These 4 genes are involved in error correction (mismatch repair), so dysfunction of the genes can lead to the inability to fix DNA replication errors and cause Lynch syndrome. Lynch syndrome is known to be associated
773:
mutations are more likely to be Amsterdam criteria II-negative. The presentation with MSH6 is slightly different from with MLH1 and MSH2, and the term "MSH6 syndrome" has been used to describe this condition. In one study, the Bethesda guidelines were more sensitive than the Amsterdam Criteria in
3154:
Stjepanovic N, Moreira L, Carneiro F, Balaguer F, Cervantes A, Balmaña J, Martinelli E; ESMO Guidelines Committee. Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow- up†. Ann Oncol. 2019 Oct 1;30(10):1558-1571. doi: 10.1093/annonc/mdz233.
1186:. Lynch syndrome-causing mutations are found in approximately 3% of all diagnosed colorectal cancers, and 1.8% of all diagnosed endometrial cancers. The average age of diagnosis of cancer in patients with this syndrome is 44 years old, as compared to 64 years old in people without the syndrome. 3271:
André, Thierry; Shiu, Kai-Keen; Kim, Tae Won; Jensen, Benny Vittrup; Jensen, Lars Henrik; Punt, Cornelis; Smith, Denis; Garcia-Carbonero, Rocio; Benavides, Manuel; Gibbs, Peter; de la Fouchardiere, Christelle; Rivera, Fernando; Elez, Elena; Bendell, Johanna; Le, Dung T.; Yoshino, Takayuki; Van
1169:
Though the exact prevalence of Lynch syndrome-causing mutations in the general population remain unknown, recent studies estimate the prevalence to be 1 in 279 individuals, or 0.35%. Certain populations are known to have a higher prevalence of founder mutations, including, but not limited to,
935:
are recommended as a preventative method of surveillance for individuals who have Lynch syndrome, or LS-associated genes. Specifically, it is recommended that colonoscopies begin at ages 20–25 for MLH1 and MSH2 mutation carriers and 35 years for MSH6 and PMS2 mutation carriers. Colonoscopic
817:(MSI) testing. In the US, professional societies recommend testing every colon cancer for MSI or IHC as screening for Lynch syndrome, but this is not always performed because of cost and resource limitations. Genetic testing is commercially available and consists of a blood test. 1129:
or total colectomy with ileorectal anastomosis. Due to increased risk of colorectal cancer following partial colectomy and similar quality of life after both surgeries, a total colectomy may be a preferred treatment for Lynch syndrome, especially in younger patients.
952:
is recommended annually for ovarian and endometrial cancer screening. For women with Lynch syndrome, a yearly CA-125 blood test can be used to screen for ovarian cancer, however there is limited data on the efficacy of this test in reducing mortality.
2393:
Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, et al. (August 2014). "Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer".
275:
diagnosis is 44 for members of families that meet the Amsterdam criteria. The average age of diagnosis of endometrial cancer is about 46 years. Among women with HNPCC who have both colon and endometrial cancer, about half present first with
1493:
Sobocińska, Joanna; Kolenda, Tomasz; Teresiak, Anna; Badziąg-Leśniak, Natalia; Kopczyńska, Magda; Guglas, Kacper; Przybyła, Anna; Filas, Violetta; Bogajewska-Ryłko, Elżbieta; Lamperska, Katarzyna; Mackiewicz, Andrzej (2020-10-05).
961:
There are also strategies for detecting other cancers early or reducing the chances of developing them that people with Lynch syndrome can discuss with their doctor, however their effectiveness is not clear. These options include:
284:
is 56 years of age with intestinal-type adenocarcinoma being the most commonly reported pathology. HNPCC-associated ovarian cancers have an average age of diagnosis of 42.5 years-old; approximately 30% are diagnosed before age 40.
2774:"Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG)" 1071:
Presence of synchronous or metachronous colorectal or other Lynch syndrome associated cancers (e.g. cancers of endometrium, ovary, stomach, small bowel, pancreas, biliary tract, ureter, renal pelvis, brain, sebaceous glands,
2234:
Ramsoekh D, Wagner A, van Leerdam ME, Dinjens WN, Steyerberg EW, Halley DJ, et al. (November 2008). "A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting".
861:, suggesting that tumor-infiltrating lymphocytes might be a good option for therapy for these patients. High numbers of tumor-infiltrating lymphocytes were related with better survival rates and treatment responses. 856:
analysis of microsatellite regions. MSI analysis can be used to identify people who may have Lynch syndrome and direct them for further testing. One study noted that one third of MSI colorectal cancers showed a low
3998: 3979: 2372: 1553:
Møller, Pål; Seppälä, Toni T.; Bernstein, Inge; Holinski-Feder, Elke; Sala, Paulo; Gareth Evans, D.; Lindblom, Annika; Macrae, Finlay; Blanco, Ignacio; Sijmons, Rolf H.; Jeffries, Jacqueline (2018).
2955:
Vasen, Hans F A; Blanco, Ignacio; Aktan-Collan, Katja; Gopie, Jessica P; Alonso, Angel; Aretz, Stefan; Bernstein, Inge; Bertario, Lucio; Burn, John; Capella, Gabriel; Colas, Chrystelle (June 2013).
4726: 280:, making endometrial cancer the most common sentinel cancer in Lynch syndrome. The most common symptom of endometrial cancer is abnormal vaginal bleeding. In HNPCC, the mean age of diagnosis of 288:
Significant variation in the rate of cancer has been found depending on the mutation involved. Up to the age of 75 years the risks of different cancers by the mutations are in the table below.
1387:
Vogel JD, Eskicioglu C, Weiser MR, Feingold DL, Steele SR (October 2017). "The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Treatment of Colon Cancer".
2034:
Miyaki M, Konishi M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Yasuno M, et al. (November 1997). "Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer".
848:). MSI is associated with alternate sized repetitive DNA sequences that are not present in the correlated germ line DNA resulting in 15-20% of colorectal cancers. MSI is identified through 1089:
It is important to note that these clinical criteria can be difficult to use in practice and clinical criteria used alone misses between 12 and 68 percent of Lynch syndrome cases.
1828:
Tamura K, Kaneda M, Futagawa M, Takeshita M, Kim S, Nakama M, et al. (September 2019). "Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome".
2080:
Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, et al. (September 1994). "Mutations of two PMS homologues in hereditary nonpolyposis colon cancer".
4719: 2131:
Lu SL, Kawabata M, Imamura T, Akiyama Y, Nomizu T, Miyazono K, Yuasa Y (May 1998). "HNPCC associated with germline mutation in the TGF-beta type II receptor gene".
4972: 840:
Mutations in DNA mismatch repair systems can lead to difficulty transmitting regions within the DNA which contain repeating patterns of two or three nucleotides (
4992: 4712: 3815:"Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic" 1085:
Person with colorectal cancer and two or more first- or second-degree relatives with colorectal cancer or Lynch syndrome associated cancer diagnosed at any age.
1082:
Colorectal cancer diagnosed in a person with one or more first-degree relative with colorectal cancer or Lynch syndrome associated tumour diagnosed under age 50
2329:
Goldberg Y, Porat RM, Kedar I, Shochat C, Galinsky D, Hamburger T, et al. (June 2010). "An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC".
1005:
Amsterdam I Criteria (all bullet points must be fulfilled): The Amsterdam I criteria were published in 1990; however, were felt to be insufficiently sensitive.
232:
In addition to the types of cancer found in the chart above, it is understood that Lynch syndrome also contributes to an increased risk of small bowel cancer,
1010:
Three or more family members with a confirmed diagnosis of colorectal cancer, one of whom is a first degree (parent, child, sibling) relative of the other two
2376: 4163: 1125:
Surgery remains the front-line therapy for Lynch syndrome. Patients with Lynch syndrome who develop colorectal cancer may be treated with either a partial
3478: 1991:
Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, et al. (March 1994). "Mutation of a mutL homolog in hereditary colon cancer".
3014:"New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC" 4102: 3175:"The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside" 2436:"Artificial Intelligence for Histology-Based Detection of Microsatellite Instability and Prediction of Response to Immunotherapy in Colorectal Cancer" 1744:"Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review" 3678:"Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds" 3346: 1703:"Mutated gene-specific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair" 1555:"Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database" 1153:
In 2024 development for a vaccine called LynchVax that would reduce the risk of cancer from the disease has been started by scientist from the
1145:
Checkpoint blockade with anti-PD-1 therapy is now preferred first line therapy for advanced Microsatellite-Instability–High colorectal cancer.
3500:
Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ (February 1966). "Hereditary factors in cancer. Study of two large midwestern kindreds".
3727:"Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability" 4394: 3726: 551:
MLH1 protein dimerizes with PMS2 protein to form MutLα, which coordinates the binding of other proteins involved with mismatch repair like
150: 4270: 1026:
The Amsterdam II criteria were developed in 1999 and improved the diagnostic sensitivity for Lynch syndrome by including cancers of the
2824:
Ring KL, Garcia C, Thomas MH, Modesitt SC (November 2017). "Current and future role of genetic screening in gynecologic malignancies".
3814: 1952:"Lynch Syndrome and Muir-Torre Syndrome: An update and review on the genetics, epidemiology, and management of two related disorders" 1685: 1423: 4156: 4644: 3062:
Vindigni SM, Kaz AM (April 2016). "Universal Screening of Colorectal Cancers for Lynch Syndrome: Challenges and Opportunities".
924:
and genetic testing are recommended for families that meet the Amsterdam criteria, preferably before the onset of colon cancer.
805:
gene, identified by genetic testing. Candidates for germline genetic testing can be identified by clinical criteria such as the
4504: 3629:"Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X" 2555: 2499: 3938: 4189: 3766:"Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability" 3535:
Bellizzi AM, Frankel WL (November 2009). "Colorectal cancer due to deficiency in DNA mismatch repair function: a review".
2957:"Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts" 4693: 4649: 4149: 4017: 1198: 4704: 1435: 1683:
Pathology of Hereditary Nonpolyposis Colorectal Cancer - JASS 910 (1): 62 - Annals of the New York Academy of Sciences
1496:"Diagnostics of Mutations in MMR/EPCAM Genes and Their Role in the Treatment and Care of Patients with Lynch Syndrome" 1228:, AliveAndKickn, Lynch Syndrome UK and Bowel Cancer UK. In the US, National Lynch Syndrome Awareness Day is March 22. 4256: 802: 623: 450: 4767: 2176:"Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome" 1915:
Yurgelun MB, Hampel H (May 2018). "Recent Advances in Lynch Syndrome: Diagnosis, Treatment, and Cancer Prevention".
4947: 4821: 4552: 2551:"Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation" 4136: 2708:
Taieb, Julien; Svrcek, Magali; Cohen, Romain; Basile, Debora; Tougeron, David; Phelip, Jean-Marc (November 2022).
4870: 556: 1137:-based adjuvant therapies for Lynch syndrome-related colorectal tumours, particularly those in stages I and II. 1039:
Three or more family members with HNPCC-related cancers, one of whom is a first-degree relative of the other two
4987: 4743: 4654: 4457: 4414: 4385: 3877: 1048: 1019: 43: 4926: 4365: 4126: 2925: 2867:
Sroczynski G, Gogollari A, Conrads-Frank A, Hallsson LR, Pashayan N, Widschwendter M, Siebert U (July 2020).
2607:"Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer" 1917:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
2869:"Cost-Effectiveness of Early Detection and Prevention Strategies for Endometrial Cancer-A Systematic Review" 1216:
Complicating matters is the presence of an alternative set of criteria, known as the "Bethesda Guidelines."
1001:
The following are the Amsterdam criteria in identifying high-risk candidates for molecular genetic testing:
4683: 4357: 4180: 4110: 1225: 985: 4115: 4099: 4982: 4735: 4623: 4399: 4375: 3272:
Cutsem, Eric; Yang, Ping; Farooqui, Mohammed Z.H.; Marinello, Patricia; Diaz, Luis A. (3 December 2020).
2710:"Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment" 4085: 3579: 4977: 4893: 4848: 4809: 4639: 4380: 4361: 4234: 887: 870: 845: 814: 521: 51: 31: 4121: 3676:
Scott RJ, McPhillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD, et al. (January 2001).
2434:
Hildebrand, Lindsey A.; Pierce, Colin J.; Dennis, Michael; Paracha, Munizay; Maoz, Asaf (2021-01-21).
2203: 4888: 4547: 4476: 4172: 3813:
Lipton LR, Johnson V, Cummings C, Fisher S, Risby P, Eftekhar Sadat AT, et al. (December 2004).
3764:
Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, RĂĽschoff J, et al. (February 2004).
1793:
Peltomäki P (March 2003). "Role of DNA mismatch repair defects in the pathogenesis of human cancer".
853: 252:
has also been associated with Lynch syndrome, although this relationship is not entirely understood.
3580:"Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome" 1250:"Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer" 4942: 4499: 4353: 4130: 4034: 1876:"The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer" 1742:
Yokoyama T, Takehara K, Sugimoto N, Kaneko K, Fujimoto E, Okazawa-Sakai M, et al. (May 2018).
1117:
to prevent cancer from developing) can be performed before ovarian or endometrial cancer develops.
74: 2175: 4865: 4688: 4437: 4206: 2549:
Snowsill T, Coelho H, Huxley N, Jones-Hughes T, Briscoe S, Frayling IM, Hyde C (September 2017).
2493:
Snowsill T, Huxley N, Hoyle M, Jones-Hughes T, Coelho H, Cooper C, et al. (September 2014).
945: 119: 3842: 4788: 4529: 4317: 4279: 971: 3112:
Bui QM, Lin D, Ho W (February 2017). "Approach to Lynch Syndrome for the Gastroenterologist".
1064:
If a person meets any 1 of 5 criteria the tumour(s) from the person should be tested for MSI:
4831: 4389: 1874:
Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, et al. (December 1993).
1102: 974:
cancer every 3–5 years, starting at age 30 at the earliest (preferably in a research setting)
2772:
Monahan KJ, Bradshaw N, Dolwani S, Desouza B, Dunlop MG, East JE, et al. (March 2020).
1307:
Kastrinos F, Mukherjee B, Tayob N, Wang F, Sparr J, Raymond VM, et al. (October 2009).
1224:
There are a number of non-profit organisations providing information and support, including
4534: 2089: 2000: 1154: 825: 810: 533: 237: 47: 1682: 1441: 936:
surveillance should then be performed at a 1-2 year interval for Lynch Syndrome patients.
8: 4930: 4852: 4734: 4002: 2657: 2495:"A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome" 1205: 1079:
Colorectal cancer with MSI-high pathology in a person who is younger than 60 years of age
910: 898:
but researchers are trying to use artificial intelligence to predict MSI from histology.
829: 798: 580: 517: 241: 139: 138:. The increased risk for these cancers is due to inherited genetic mutations that impair 3898: 2756: 2174:
Ou J, Rasmussen M, Westers H, Andersen SD, Jager PO, Kooi KA, et al. (April 2009).
2093: 2004: 4594: 4576: 4516: 4345: 4341: 3790: 3765: 3702: 3677: 3653: 3628: 3604: 3560: 3455: 3430: 3401: 3376: 3303: 3248: 3223: 3222:
Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, et al. (June 2015).
3199: 3174: 3137: 3087: 2989: 2956: 2895: 2868: 2849: 2798: 2773: 2739: 2685: 2633: 2606: 2577: 2521: 2470: 2435: 2354: 2306: 2279: 2260: 2216: 2156: 2113: 2059: 1853: 1770: 1743: 1647: 1587: 1554: 1530: 1495: 1333: 1308: 1284: 1249: 1209: 1158: 949: 921: 806: 778: 513: 505: 277: 123: 107: 103: 16:
Autosomal dominant genetic condition associated with a high risk of cancer in the colon
4011: 4007: 3030: 3013: 4817: 4661: 4613: 4604: 4327: 4229: 4198: 4045: 3944: 3934: 3834: 3795: 3746: 3707: 3658: 3627:
Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, et al. (April 2005).
3609: 3552: 3517: 3460: 3406: 3307: 3295: 3253: 3204: 3156: 3129: 3079: 3035: 2994: 2976: 2900: 2841: 2803: 2743: 2731: 2690: 2638: 2582: 2526: 2475: 2457: 2411: 2346: 2311: 2252: 2208: 2148: 2105: 2051: 2016: 1973: 1932: 1897: 1892: 1875: 1857: 1845: 1810: 1775: 1724: 1639: 1631: 1592: 1574: 1535: 1517: 1475: 1431: 1404: 1338: 1289: 1271: 1179: 794: 544: 272: 233: 63: 3564: 3141: 2853: 2358: 2264: 2220: 2160: 2063: 1950:
Le S, Ansari U, Mumtaz A, Malik K, Patel P, Doyle A, Khachemoune A (November 2017).
1651: 500: 4462: 4336: 4251: 4239: 3826: 3785: 3777: 3738: 3725:
Gologan A, Krasinskas A, Hunt J, Thull DL, Farkas L, Sepulveda AR (November 2005).
3697: 3689: 3648: 3640: 3599: 3591: 3544: 3509: 3450: 3442: 3396: 3388: 3285: 3243: 3235: 3194: 3186: 3121: 3091: 3071: 3025: 2984: 2968: 2890: 2880: 2833: 2793: 2785: 2721: 2680: 2672: 2628: 2618: 2572: 2564: 2516: 2508: 2465: 2447: 2403: 2338: 2301: 2291: 2244: 2198: 2190: 2140: 2117: 2097: 2043: 2008: 1963: 1924: 1887: 1837: 1802: 1765: 1755: 1714: 1665: 1623: 1582: 1566: 1525: 1507: 1396: 1361: 1328: 1320: 1279: 1261: 1171: 543:
The 4 main genes involved in Lynch syndrome normally encode for proteins that form
3377:"Recent progress in Lynch syndrome and other familial colorectal cancer syndromes" 4921: 4751: 4739: 4304: 4287: 4106: 4039: 3742: 3548: 3321: 2759:. From Medscape. By Juan Carlos Munoz and Louis R Lambiase. Updated: Oct 31, 2011 2407: 1689: 1400: 1073: 883: 315: 256: 245: 143: 1610:
Ring, Kari L.; Garcia, Christine; Thomas, Martha H.; Modesitt, Susan C. (2017).
1512: 309:
upper gastrointestinal (gastric, duodenal, bile duct or pancreatic) cancer risk
4937: 4916: 4838: 4618: 4581: 4511: 4409: 4349: 4292: 4221: 4211: 3513: 3446: 2972: 2837: 2789: 2726: 2709: 1841: 1627: 1570: 1463: 1194: 1183: 1134: 1110: 978: 967: 849: 841: 560: 303: 281: 115: 111: 4074: 4050: 3948: 3595: 3190: 3125: 3075: 2342: 2296: 1760: 777:
Up to 39% of families with mutations in a Lynch syndrome gene do not meet the
4966: 4910: 4826: 4562: 4244: 4141: 3644: 3274:"Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer" 2980: 2461: 1635: 1578: 1521: 1275: 1266: 932: 249: 168:
Lifetime risk and mean age at diagnosis for Lynch syndrome–associated cancers
127: 4137:
National Cancer Institute: Genetics of Colorectal Cancer information summary
3992: 3988: 3830: 2885: 2623: 2605:
Evrard C, Tachon G, Randrian V, Karayan-Tapon L, Tougeron D (October 2019).
2452: 2248: 2012: 1806: 566:
MSH2 protein dimerizes with MSH6 protein, which identifies mismatches via a
4524: 3838: 3799: 3750: 3711: 3662: 3613: 3556: 3464: 3410: 3299: 3257: 3208: 3160: 3133: 3083: 3039: 2998: 2904: 2845: 2807: 2735: 2694: 2676: 2642: 2586: 2530: 2479: 2415: 2350: 2315: 2256: 2212: 1977: 1936: 1849: 1814: 1779: 1728: 1719: 1702: 1643: 1611: 1596: 1539: 1479: 1408: 1342: 1324: 1293: 1098: 894:
The histopathological criteria are not sensitive enough to detect MSI from
264: 92: 55: 3781: 3521: 3290: 3273: 3239: 2152: 2109: 2055: 2020: 1901: 1612:"Current and future role of genetic screening in gynecologic malignancies" 4880: 4589: 4542: 4485: 4429: 4069: 1968: 1951: 1056:
information to help health care providers identify persons at high risk.
1027: 989: 858: 268: 135: 131: 2866: 2656:
Nouri Nojadeh, Jafar; Behrouz Sharif, Shahin; Sakhinia, Ebrahim (2018).
1928: 1492: 4800: 4777: 4675: 3392: 2047: 1175: 981:, starting at age 30 at the earliest (preferably in a research setting) 852:
from both a tumor tissue sample and a normal tissue sample followed by
537: 106:
genetic condition that is associated with a high risk of colon cancer,
39: 3971: 2194: 2144: 1869: 1867: 1208:
defect, and use the term "familial colorectal cancer type X" when the
1204:
Other sources reserve the term "Lynch syndrome" when there is a known
909:(HNPCC associated with other cancers of the gastrointestinal tract or 4571: 4494: 4312: 3856: 2568: 2550: 2512: 2494: 2101: 1126: 1045:
One or more of the HNPCC-related cancers diagnosed under age 50 years
895: 567: 529: 3931:
Daughter of Family G. : a memoir of cancer genes, love and fate
2033: 1552: 4782: 4761: 4634: 4080: 3693: 2655: 1864: 552: 260: 68: 2604: 520:, which causes an elevated rate of single nucleotide changes and 4028: 4025: 4022: 3675: 3347:"Work starts on a cancer vaccine for people with Lynch syndrome" 2548: 2233: 873:– MSI) cancers can be recognized by histopathological criteria: 641: 610: 524:, also known as MSI-H (the H is "high"). MSI is identifiable in 3983: 2492: 1106: 732: 525: 1990: 1741: 2771: 2433: 2392: 1827: 1386: 1114: 3486: 2954: 2079: 1034:
Amsterdam Criteria II (all bullet points must be fulfilled):
4631: 3899:"CDC: March 22nd is National Lynch Syndrome Awareness Day!" 3812: 2373:"Fact Sheet 33 | BOWEL CANCER AND INHERITED PREDISPOSITION" 1309:"Risk of pancreatic cancer in families with Lynch syndrome" 1306: 752: 711: 690: 669: 648: 617: 589: 576: 532:
laboratory. Most cases result in changes in the lengths of
480: 465: 444: 429: 3724: 2173: 793:
A diagnosis of Lynch syndrome is applied to people with a
259:
and common signs and symptoms include blood in the stool,
3322:"Lynchvax: Vaccine hope for cancer risk genetic disorder" 3224:"PD-1 Blockade in Tumors with Mismatch-Repair Deficiency" 2328: 1461: 3763: 2823: 2130: 1609: 3626: 3499: 3172: 3011: 1873: 3012:
Vasen HF, Watson P, Mecklin JP, Lynch HT (June 1999).
2707: 1700: 1161:
but clinical trials are far from being conducted yet.
1016:
One or more colon cancers diagnosed under age 50 years
828:(IHC) is a method that can be used to detect abnormal 809:
and Bethesda Guidelines, or through tumor analysis by
1462:
Braun MM, Overbeek-Wager EA, Grumbo RJ (March 2016).
516:
fashion. The hallmark of Lynch syndrome is defective
3961: 3428: 3374: 1133:
There is an ongoing controversy over the benefit of
149:
Other HNPCC conditions include Lynch-like syndrome,
1949: 1701:Oki E, Oda S, Maehara Y, Sugimachi K (March 1999). 992:
or spinal cord), starting at age 25 at the earliest
3270: 3221: 1248:Carethers, John M; Stoffel, Elena M (2015-08-21). 844:), otherwise known as microsatellite instability ( 3173:Boland CR, Koi M, Chang DK, Carethers JM (2007). 2658:"Microsatellite instability in colorectal cancer" 984:Annual physical and neurological exams to detect 4964: 1464:"Diagnosis and Management of Endometrial Cancer" 1247: 886:in any location showing any measurable level of 540:cytosine and adenine (sequence: CACACACACA...). 4973:DNA replication and repair-deficiency disorders 4116:GeneReviews/NCBI/NIH/UW entry on Lynch syndrome 3731:Archives of Pathology & Laboratory Medicine 3534: 3429:Biller LH, Syngal S, Yurgelun MB (April 2019). 1430:(2nd ed.). New York: McGraw-Hill Medical. 4993:Syndromes affecting the gastrointestinal tract 4171: 3375:Boland PM, Yurgelun MB, Boland CR (May 2018). 2075: 2073: 1914: 98:HNPCC includes (and was once synonymous with) 54:-H tumours, as may be seen in Lynch syndrome. 4720: 4157: 2826:American Journal of Obstetrics and Gynecology 2701: 2429: 2427: 2425: 2277: 1616:American Journal of Obstetrics and Gynecology 835: 412:Risk of gynecologic cancer in Lynch syndrome 3806: 3757: 3718: 3669: 3620: 3571: 2322: 2271: 2227: 2167: 1141:Anti-PD-1 antibody therapy can be effective. 151:polymerase proofreading-associated polyposis 3493: 3061: 2124: 2070: 4727: 4713: 4164: 4150: 3953:Paperback version retitled Before My Time. 3584:Surgical Oncology Clinics of North America 2422: 2204:11370/b74f7d2b-12fb-4bfc-a8c8-2d8950e81972 1830:International Journal of Clinical Oncology 1213:have a DNA-mismatch-repair gene mutation. 801:genes (MLH1, MSH2, MSH6, and PMS2) or the 73: 30: 4861:Hereditary nonpolyposis colorectal cancer 4420:Hereditary nonpolyposis colorectal cancer 3789: 3701: 3652: 3603: 3454: 3400: 3289: 3247: 3198: 3029: 2988: 2894: 2884: 2797: 2725: 2684: 2632: 2622: 2576: 2520: 2469: 2451: 2305: 2295: 2202: 1967: 1891: 1792: 1769: 1759: 1718: 1586: 1529: 1511: 1332: 1283: 1265: 1068:Colorectal cancer diagnosed before age 50 877:right-sided poorly differentiated cancers 598:Frequency of mutations in HNPCC families 255:Two-thirds of colon cancers occur in the 85:Hereditary nonpolyposis colorectal cancer 25:Hereditary nonpolyposis colorectal cancer 3770:Journal of the National Cancer Institute 3528: 3111: 1030:, small bowel, ureter and renal pelvis. 499: 4645:Intraductal papillary mucinous neoplasm 2757:Hereditary Colorectal Cancer Background 1421: 901:In addition, HNPCC can be divided into 820: 153:and familial colorectal cancer type X. 4965: 3577: 2600: 2598: 2596: 2284:Hereditary Cancer in Clinical Practice 4708: 4145: 3928: 3424: 3422: 3420: 3370: 3368: 3366: 3107: 3105: 3103: 3101: 3057: 3055: 3053: 3051: 3049: 2950: 2948: 2946: 2920: 2918: 2916: 2914: 2819: 2817: 2767: 2765: 2544: 2542: 2540: 2388: 2386: 1356: 1354: 1352: 1243: 1241: 996: 156: 3344: 2649: 986:cancer in the central nervous system 570:, a protein for scanning for errors. 91:) is a hereditary predisposition to 4694:Desmoplastic small round cell tumor 3933:. Toronto: Alfred A. Knopf Canada. 3431:"Recent advances in Lynch syndrome" 3381:CA: A Cancer Journal for Clinicians 3228:The New England Journal of Medicine 2593: 1199:Creighton University Medical Center 1042:Two successive affected generations 1013:Two successive affected generations 557:single-stranded-DNA binding-protein 13: 4395:Polymerase proofreading-associated 3917: 3682:American Journal of Human Genetics 3417: 3363: 3098: 3046: 2943: 2911: 2814: 2762: 2537: 2383: 1349: 1238: 512:Lynch syndrome is inherited in an 14: 5004: 4257:Hereditary diffuse gastric cancer 3957: 3878:"Bowel Cancer UK: Lynch Syndrome" 2278:Suchy J, Lubinski J (June 2008). 1254:World Journal of Gastroenterology 864: 161: 4948:Severe combined immunodeficiency 4553:Nodular regenerative hyperplasia 3351:Cancer Research UK - Cancer News 1424:"Chapter 33: Endometrial Cancer" 1389:Diseases of the Colon and Rectum 4871:Mismatch repair cancer syndrome 3891: 3870: 3849: 3471: 3338: 3314: 3278:New England Journal of Medicine 3264: 3215: 3166: 3148: 3114:Digestive Diseases and Sciences 3064:Digestive Diseases and Sciences 3005: 2860: 2750: 2486: 2365: 2183:Genes, Chromosomes & Cancer 2027: 1984: 1943: 1908: 1821: 1786: 1735: 1694: 1676: 1658: 1164: 4744:DNA repair-deficiency disorder 4655:Solid pseudopapillary neoplasm 4458:Gastrointestinal stromal tumor 4415:Familial adenomatous polyposis 3537:Advances in Anatomic Pathology 1603: 1546: 1486: 1455: 1415: 1380: 1300: 1189: 1049:Familial adenomatous polyposis 1020:Familial adenomatous polyposis 236:, ureter/renal pelvis cancer, 182:Mean age at diagnosis (years) 44:tumor-infiltrating lymphocytes 1: 4463:Krukenberg tumor (metastatic) 3502:Archives of Internal Medicine 3031:10.1016/S0016-5085(99)70510-X 1231: 869:Three major groups of MSI-H ( 50:), a finding associated with 4822:DeSanctis–Cacchione syndrome 4768:Aicardi–Goutières syndrome 4 4684:Primary peritoneal carcinoma 4358:traditional serrated adenoma 4111:National Institute of Health 3819:Journal of Clinical Oncology 3743:10.5858/2005-129-1390-POTRBG 3549:10.1097/PAP.0b013e3181bb6bdc 2556:Health Technology Assessment 2500:Health Technology Assessment 2408:10.1053/j.gastro.2014.04.001 1893:10.1016/0092-8674(93)90546-3 1795:Journal of Clinical Oncology 1401:10.1097/DCR.0000000000000926 1226:Lynch Syndrome International 1120: 977:Annual urinalysis to detect 966:Upper endoscopies to detect 916: 905:(familial colon cancer) and 880:right-sided mucinous cancers 788: 7: 4624:Pancreatic ductal carcinoma 1513:10.3390/diagnostics10100786 1197:, Professor of Medicine at 1148: 1060:Revised Bethesda Guidelines 807:Amsterdam Clinical Criteria 495: 312:urinary tract cancers risk 10: 5009: 4894:Nijmegen breakage syndrome 4810:Nucleotide excision repair 4640:Serous microcystic adenoma 4235:Signet ring cell carcinoma 4173:Digestive system neoplasia 3578:Lindor NM (October 2009). 3514:10.1001/archinte.117.2.206 3447:10.1007/s10689-018-00117-1 2973:10.1136/gutjnl-2012-304356 2838:10.1016/j.ajog.2017.04.011 2790:10.1136/gutjnl-2019-319915 2727:10.1016/j.ejca.2022.07.020 2714:European Journal of Cancer 1956:Dermatology Online Journal 1842:10.1007/s10147-019-01494-y 1628:10.1016/j.ajog.2017.04.011 1571:10.1136/gutjnl-2017-314057 1219: 1092: 940:Endometrial/ovarian cancer 888:intraepithelial lymphocyte 871:microsatellite instability 836:Microsatellite instability 815:microsatellite instability 595:Genes implicated in HNPCC 522:microsatellite instability 4927:Rothmund–Thomson syndrome 4902: 4879: 4847: 4808: 4799: 4750: 4674: 4603: 4561: 4548:Focal nodular hyperplasia 4484: 4475: 4450: 4428: 4326: 4303: 4278: 4269: 4220: 4197: 4188: 4179: 4060: 3965: 3596:10.1016/j.soc.2009.07.003 3191:10.1007/s10689-007-9145-9 3126:10.1007/s10620-016-4346-4 3076:10.1007/s10620-015-3964-6 2343:10.1007/s10689-009-9298-9 2297:10.1186/1897-4287-6-2-103 1761:10.1186/s12885-018-4489-0 1468:American Family Physician 504:HNPCC is inherited in an 62: 38: 29: 24: 4650:Mucinous cystic neoplasm 4500:Hepatocellular carcinoma 4354:sessile serrated adenoma 3922: 3645:10.1001/jama.293.16.1979 3345:Gunn, Tim (2024-09-09). 1267:10.3748/wjg.v21.i31.9253 575:with other mutations in 423:Endometrial cancer risk 300:endometrial cancer risk 4759:Separation/initiation: 4689:Peritoneal mesothelioma 4438:Squamous cell carcinoma 4207:Squamous cell carcinoma 3831:10.1200/JCO.2004.11.084 2926:"Medical Options | CDC" 2886:10.3390/cancers12071874 2624:10.3390/cancers11101567 2453:10.3390/cancers13030391 2249:10.1136/gut.2008.156695 2013:10.1126/science.8128251 1807:10.1200/JCO.2003.04.060 1670:Genetics Home Reference 1051:(FAP) has been excluded 1022:(FAP) has been excluded 946:transvaginal ultrasound 297:colorectal cancer risk 4789:Dyskeratosis congenita 4530:Hepatocellular adenoma 4318:Pseudomyxoma peritonei 2677:10.17179/EXCLI2017-948 1720:10.1038/sj.onc.1202583 1325:10.1001/jama.2009.1529 696:relatively infrequent 509: 110:(second most common), 4988:Syndromes with tumors 4889:Ataxia–telangiectasia 4832:Xeroderma pigmentosum 3291:10.1056/NEJMoa2017699 3240:10.1056/NEJMoa1500596 1103:salpingo-oophorectomy 795:germline DNA mutation 503: 4943:Li–Fraumeni syndrome 4535:Cavernous hemangioma 4386:Familial adenomatous 4373:Polyposis syndromes: 1969:10.5070/D32311037239 1155:University of Oxford 826:Immunohistochemistry 821:Immunohistochemistry 811:immunohistochemistry 534:dinucleotide repeats 420:Ovarian cancer risk 244:. Increased risk of 240:, brain cancer, and 238:biliary tract cancer 4931:RAPADILINO syndrome 4866:Muir–Torre syndrome 4853:DNA mismatch repair 3929:McKay, Ami (2019). 3857:"Lynch Syndrome UK" 3782:10.1093/jnci/djh034 2094:1994Natur.371...75N 2005:1994Sci...263.1625P 1929:10.1200/EDBK_208341 1428:Williams Gynecology 1422:Hoffman BL (2012). 1368:. February 22, 2019 1206:DNA mismatch repair 911:reproductive system 581:DNA mismatch repair 568:sliding clamp model 518:DNA mismatch repair 486:6% (combined risk) 413: 242:sebaceous neoplasms 140:DNA mismatch repair 124:hepatobiliary tract 4983:Hereditary cancers 4595:Gallbladder cancer 4577:Cholangiocarcinoma 4517:Liver angiosarcoma 4451:Upper and/or lower 4400:Serrated polyposis 4105:2007-08-15 at the 4061:External resources 3393:10.3322/caac.21448 2048:10.1038/ng1197-271 1688:2006-06-19 at the 1210:Amsterdam criteria 1159:Cancer Research UK 1157:with a grant from 997:Amsterdam criteria 950:endometrial biopsy 922:Genetic counseling 779:Amsterdam criteria 660:Papadopoulos 1994 654:approximately 30% 629:approximately 60% 604:First publication 514:autosomal dominant 510: 506:autosomal dominant 411: 278:endometrial cancer 271:. The mean age of 179:Lifetime risk (%) 157:Signs and symptoms 142:. It is a type of 108:endometrial cancer 104:autosomal dominant 4978:Colorectal cancer 4960: 4959: 4956: 4955: 4818:Cockayne syndrome 4736:Metabolic disease 4702: 4701: 4670: 4669: 4662:Pancreatoblastoma 4614:exocrine pancreas 4471: 4470: 4446: 4445: 4265: 4264: 4230:Gastric carcinoma 4095: 4094: 3940:978-0-345-80946-9 3489:on July 22, 2011. 3284:(23): 2207–2218. 2195:10.1002/gcc.20644 2145:10.1038/ng0598-17 1260:(31): 9253–9261. 1180:African Americans 907:Lynch syndrome II 767: 766: 528:specimens in the 493: 492: 409: 408: 321:brain tumor risk 273:colorectal cancer 267:, and unintended 234:pancreatic cancer 230: 229: 82: 81: 48:colorectal cancer 19:Medical condition 5000: 4806: 4805: 4729: 4722: 4715: 4706: 4705: 4482: 4481: 4381:MUTYH-associated 4366:Cronkhite–Canada 4337:Colorectal polyp 4276: 4275: 4252:Linitis plastica 4240:Gastric lymphoma 4195: 4194: 4186: 4185: 4166: 4159: 4152: 4143: 4142: 3963: 3962: 3952: 3911: 3910: 3908: 3906: 3895: 3889: 3888: 3886: 3884: 3874: 3868: 3867: 3865: 3863: 3853: 3847: 3846: 3841:. Archived from 3810: 3804: 3803: 3793: 3761: 3755: 3754: 3722: 3716: 3715: 3705: 3673: 3667: 3666: 3656: 3624: 3618: 3617: 3607: 3575: 3569: 3568: 3532: 3526: 3525: 3497: 3491: 3490: 3485:. Archived from 3483:www.oncolink.org 3475: 3469: 3468: 3458: 3426: 3415: 3414: 3404: 3372: 3361: 3360: 3358: 3357: 3342: 3336: 3335: 3333: 3332: 3318: 3312: 3311: 3293: 3268: 3262: 3261: 3251: 3219: 3213: 3212: 3202: 3170: 3164: 3152: 3146: 3145: 3109: 3096: 3095: 3059: 3044: 3043: 3033: 3018:Gastroenterology 3009: 3003: 3002: 2992: 2952: 2941: 2940: 2938: 2937: 2922: 2909: 2908: 2898: 2888: 2864: 2858: 2857: 2821: 2812: 2811: 2801: 2769: 2760: 2754: 2748: 2747: 2729: 2705: 2699: 2698: 2688: 2662: 2653: 2647: 2646: 2636: 2626: 2602: 2591: 2590: 2580: 2569:10.3310/hta21510 2546: 2535: 2534: 2524: 2513:10.3310/hta18580 2490: 2484: 2483: 2473: 2455: 2431: 2420: 2419: 2396:Gastroenterology 2390: 2381: 2380: 2375:. Archived from 2369: 2363: 2362: 2326: 2320: 2319: 2309: 2299: 2275: 2269: 2268: 2231: 2225: 2224: 2206: 2180: 2171: 2165: 2164: 2128: 2122: 2121: 2102:10.1038/371075a0 2077: 2068: 2067: 2031: 2025: 2024: 1999:(5153): 1625–9. 1988: 1982: 1981: 1971: 1947: 1941: 1940: 1912: 1906: 1905: 1895: 1871: 1862: 1861: 1825: 1819: 1818: 1790: 1784: 1783: 1773: 1763: 1739: 1733: 1732: 1722: 1698: 1692: 1680: 1674: 1673: 1666:"Lynch Syndrome" 1662: 1656: 1655: 1607: 1601: 1600: 1590: 1565:(7): 1306–1316. 1550: 1544: 1543: 1533: 1515: 1490: 1484: 1483: 1459: 1453: 1452: 1450: 1449: 1440:. Archived from 1419: 1413: 1412: 1395:(10): 999–1017. 1384: 1378: 1377: 1375: 1373: 1362:"Lynch Syndrome" 1358: 1347: 1346: 1336: 1304: 1298: 1297: 1287: 1269: 1245: 1172:French Canadians 1105:(removal of the 1074:keratoacanthomas 948:with or without 903:Lynch syndrome I 723:Nicolaides 1994 702:Nicolaides 1994 586: 585: 579:involved in the 414: 410: 291: 290: 173: 172: 78: 77: 34: 22: 21: 5008: 5007: 5003: 5002: 5001: 4999: 4998: 4997: 4963: 4962: 4961: 4952: 4922:Werner syndrome 4898: 4875: 4843: 4795: 4752:DNA replication 4746: 4740:DNA replication 4733: 4703: 4698: 4666: 4599: 4557: 4467: 4442: 4424: 4322: 4299: 4288:Duodenal cancer 4280:Small intestine 4261: 4216: 4175: 4170: 4107:Wayback Machine 4096: 4091: 4090: 4056: 4055: 3974: 3960: 3941: 3925: 3920: 3918:Further reading 3915: 3914: 3904: 3902: 3897: 3896: 3892: 3882: 3880: 3876: 3875: 3871: 3861: 3859: 3855: 3854: 3850: 3825:(24): 4934–43. 3811: 3807: 3762: 3758: 3723: 3719: 3674: 3670: 3639:(16): 1979–85. 3625: 3621: 3576: 3572: 3533: 3529: 3498: 3494: 3477: 3476: 3472: 3435:Familial Cancer 3427: 3418: 3373: 3364: 3355: 3353: 3343: 3339: 3330: 3328: 3320: 3319: 3315: 3269: 3265: 3234:(26): 2509–20. 3220: 3216: 3179:Familial Cancer 3171: 3167: 3153: 3149: 3110: 3099: 3060: 3047: 3010: 3006: 2953: 2944: 2935: 2933: 2924: 2923: 2912: 2865: 2861: 2822: 2815: 2770: 2763: 2755: 2751: 2706: 2702: 2660: 2654: 2650: 2603: 2594: 2547: 2538: 2491: 2487: 2432: 2423: 2391: 2384: 2371: 2370: 2366: 2331:Familial Cancer 2327: 2323: 2280:"MSH6 syndrome" 2276: 2272: 2243:(11): 1539–44. 2232: 2228: 2178: 2172: 2168: 2133:Nature Genetics 2129: 2125: 2088:(6492): 75–80. 2078: 2071: 2036:Nature Genetics 2032: 2028: 1989: 1985: 1948: 1944: 1923:(38): 101–109. 1913: 1909: 1872: 1865: 1836:(9): 999–1011. 1826: 1822: 1791: 1787: 1740: 1736: 1699: 1695: 1690:Wayback Machine 1681: 1677: 1664: 1663: 1659: 1608: 1604: 1551: 1547: 1491: 1487: 1460: 1456: 1447: 1445: 1438: 1420: 1416: 1385: 1381: 1371: 1369: 1360: 1359: 1350: 1305: 1301: 1246: 1239: 1234: 1222: 1192: 1167: 1151: 1123: 1111:fallopian tubes 1095: 999: 919: 884:adenocarcinomas 867: 842:microsatellites 838: 830:mismatch repair 823: 791: 561:DNA polymerases 498: 316:prostate cancer 246:prostate cancer 176:Type of cancer 164: 159: 144:cancer syndrome 120:small intestine 72: 20: 17: 12: 11: 5: 5006: 4996: 4995: 4990: 4985: 4980: 4975: 4958: 4957: 4954: 4953: 4951: 4950: 4945: 4940: 4938:Fanconi anemia 4935: 4934: 4933: 4924: 4919: 4917:Bloom syndrome 4906: 4904: 4900: 4899: 4897: 4896: 4891: 4885: 4883: 4877: 4876: 4874: 4873: 4868: 4863: 4857: 4855: 4845: 4844: 4842: 4841: 4839:IBIDS syndrome 4836: 4835: 4834: 4824: 4814: 4812: 4803: 4797: 4796: 4794: 4793: 4792: 4791: 4773: 4772: 4771: 4770: 4756: 4754: 4748: 4747: 4732: 4731: 4724: 4717: 4709: 4700: 4699: 4697: 4696: 4691: 4686: 4680: 4678: 4672: 4671: 4668: 4667: 4665: 4664: 4658: 4657: 4652: 4647: 4642: 4627: 4626: 4621: 4619:Adenocarcinoma 4609: 4607: 4601: 4600: 4598: 4597: 4585: 4584: 4582:Klatskin tumor 4579: 4567: 4565: 4559: 4558: 4556: 4555: 4550: 4538: 4537: 4532: 4520: 4519: 4514: 4512:Hepatoblastoma 4509: 4508: 4507: 4490: 4488: 4479: 4473: 4472: 4469: 4468: 4466: 4465: 4460: 4454: 4452: 4448: 4447: 4444: 4443: 4441: 4440: 4434: 4432: 4426: 4425: 4423: 4422: 4417: 4412: 4410:Adenocarcinoma 4403: 4402: 4397: 4392: 4383: 4378: 4369: 4368: 4332: 4330: 4324: 4323: 4321: 4320: 4315: 4309: 4307: 4301: 4300: 4298: 4297: 4296: 4295: 4293:Adenocarcinoma 4284: 4282: 4273: 4267: 4266: 4263: 4262: 4260: 4259: 4254: 4249: 4248: 4247: 4237: 4232: 4226: 4224: 4218: 4217: 4215: 4214: 4212:Adenocarcinoma 4209: 4203: 4201: 4192: 4183: 4177: 4176: 4169: 4168: 4161: 4154: 4146: 4140: 4139: 4134: 4118: 4113: 4093: 4092: 4089: 4088: 4077: 4075:Lynch Syndrome 4065: 4064: 4062: 4058: 4057: 4054: 4053: 4042: 4031: 4014: 3995: 3975: 3970: 3969: 3967: 3966:Classification 3959: 3958:External links 3956: 3955: 3954: 3939: 3924: 3921: 3919: 3916: 3913: 3912: 3890: 3869: 3848: 3845:on 2013-04-15. 3805: 3756: 3737:(11): 1390–7. 3717: 3694:10.1086/316942 3688:(1): 118–127. 3668: 3619: 3570: 3527: 3492: 3470: 3441:(2): 211–219. 3416: 3387:(3): 217–231. 3362: 3337: 3313: 3263: 3214: 3165: 3147: 3120:(2): 299–304. 3097: 3045: 3004: 2967:(6): 812–823. 2942: 2910: 2859: 2832:(5): 512–521. 2813: 2784:(3): 411–444. 2761: 2749: 2700: 2648: 2592: 2536: 2485: 2421: 2382: 2379:on 2019-02-28. 2364: 2321: 2270: 2226: 2166: 2123: 2069: 2026: 1983: 1942: 1907: 1886:(5): 1027–38. 1863: 1820: 1785: 1734: 1713:(12): 2143–7. 1693: 1675: 1657: 1622:(5): 512–521. 1602: 1545: 1485: 1454: 1437:978-0071716727 1436: 1414: 1379: 1348: 1319:(16): 1790–5. 1299: 1236: 1235: 1233: 1230: 1221: 1218: 1195:Henry T. Lynch 1191: 1188: 1184:Ashkenazi Jews 1166: 1163: 1150: 1147: 1143: 1142: 1135:5-fluorouracil 1122: 1119: 1094: 1091: 1087: 1086: 1083: 1080: 1077: 1069: 1053: 1052: 1046: 1043: 1040: 1024: 1023: 1017: 1014: 1011: 998: 995: 994: 993: 982: 979:bladder cancer 975: 918: 915: 892: 891: 881: 878: 866: 865:Classification 863: 850:DNA extraction 837: 834: 822: 819: 797:in one of the 790: 787: 774:detecting it. 765: 764: 762: 759: 756: 749: 745: 744: 742: 739: 736: 729: 725: 724: 721: 718: 715: 708: 704: 703: 700: 697: 694: 687: 683: 682: 679: 676: 673: 666: 662: 661: 658: 655: 652: 645: 637: 636: 633: 630: 627: 614: 606: 605: 602: 599: 596: 593: 572: 571: 564: 497: 494: 491: 490: 487: 484: 476: 475: 472: 469: 461: 460: 457: 454: 440: 439: 436: 433: 425: 424: 421: 418: 407: 406: 403: 400: 397: 394: 391: 388: 385: 379: 378: 375: 372: 369: 366: 363: 360: 357: 351: 350: 347: 344: 341: 338: 335: 332: 329: 323: 322: 319: 313: 310: 307: 304:ovarian cancer 301: 298: 295: 282:gastric cancer 257:proximal colon 228: 227: 224: 221: 217: 216: 213: 210: 206: 205: 202: 199: 195: 194: 191: 188: 184: 183: 180: 177: 163: 162:Risk of cancer 160: 158: 155: 100:Lynch syndrome 80: 79: 66: 60: 59: 36: 35: 27: 26: 18: 15: 9: 6: 4: 3: 2: 5005: 4994: 4991: 4989: 4986: 4984: 4981: 4979: 4976: 4974: 4971: 4970: 4968: 4949: 4946: 4944: 4941: 4939: 4936: 4932: 4928: 4925: 4923: 4920: 4918: 4915: 4914: 4913: 4912: 4911:RecQ helicase 4908: 4907: 4905: 4901: 4895: 4892: 4890: 4887: 4886: 4884: 4882: 4878: 4872: 4869: 4867: 4864: 4862: 4859: 4858: 4856: 4854: 4850: 4846: 4840: 4837: 4833: 4830: 4829: 4828: 4827:Thymine dimer 4825: 4823: 4819: 4816: 4815: 4813: 4811: 4807: 4804: 4802: 4798: 4790: 4787: 4786: 4785: 4784: 4779: 4775: 4774: 4769: 4766: 4765: 4764: 4763: 4758: 4757: 4755: 4753: 4749: 4745: 4741: 4737: 4730: 4725: 4723: 4718: 4716: 4711: 4710: 4707: 4695: 4692: 4690: 4687: 4685: 4682: 4681: 4679: 4677: 4673: 4663: 4660: 4659: 4656: 4653: 4651: 4648: 4646: 4643: 4641: 4637: 4636: 4633: 4629: 4628: 4625: 4622: 4620: 4617: 4615: 4611: 4610: 4608: 4606: 4602: 4596: 4593: 4591: 4587: 4586: 4583: 4580: 4578: 4575: 4573: 4569: 4568: 4566: 4564: 4563:Biliary tract 4560: 4554: 4551: 4549: 4546: 4544: 4540: 4539: 4536: 4533: 4531: 4528: 4526: 4522: 4521: 4518: 4515: 4513: 4510: 4506: 4505:Fibrolamellar 4503: 4502: 4501: 4498: 4496: 4492: 4491: 4489: 4487: 4483: 4480: 4478: 4474: 4464: 4461: 4459: 4456: 4455: 4453: 4449: 4439: 4436: 4435: 4433: 4431: 4427: 4421: 4418: 4416: 4413: 4411: 4408: 4405: 4404: 4401: 4398: 4396: 4393: 4391: 4387: 4384: 4382: 4379: 4377: 4374: 4371: 4370: 4367: 4363: 4362:Peutz–Jeghers 4359: 4355: 4351: 4347: 4343: 4340: 4338: 4334: 4333: 4331: 4329: 4325: 4319: 4316: 4314: 4311: 4310: 4308: 4306: 4302: 4294: 4291: 4290: 4289: 4286: 4285: 4283: 4281: 4277: 4274: 4272: 4268: 4258: 4255: 4253: 4250: 4246: 4245:MALT lymphoma 4243: 4242: 4241: 4238: 4236: 4233: 4231: 4228: 4227: 4225: 4223: 4219: 4213: 4210: 4208: 4205: 4204: 4202: 4200: 4196: 4193: 4191: 4187: 4184: 4182: 4178: 4174: 4167: 4162: 4160: 4155: 4153: 4148: 4147: 4144: 4138: 4135: 4132: 4128: 4124: 4123: 4119: 4117: 4114: 4112: 4108: 4104: 4101: 4100:FAQs on HNPCC 4098: 4097: 4087: 4083: 4082: 4078: 4076: 4072: 4071: 4067: 4066: 4063: 4059: 4052: 4048: 4047: 4043: 4041: 4037: 4036: 4032: 4030: 4027: 4024: 4020: 4019: 4015: 4013: 4009: 4005: 4004: 4000: 3996: 3994: 3990: 3986: 3985: 3981: 3977: 3976: 3973: 3968: 3964: 3950: 3946: 3942: 3936: 3932: 3927: 3926: 3900: 3894: 3879: 3873: 3858: 3852: 3844: 3840: 3836: 3832: 3828: 3824: 3820: 3816: 3809: 3801: 3797: 3792: 3787: 3783: 3779: 3775: 3771: 3767: 3760: 3752: 3748: 3744: 3740: 3736: 3732: 3728: 3721: 3713: 3709: 3704: 3699: 3695: 3691: 3687: 3683: 3679: 3672: 3664: 3660: 3655: 3650: 3646: 3642: 3638: 3634: 3630: 3623: 3615: 3611: 3606: 3601: 3597: 3593: 3590:(4): 637–45. 3589: 3585: 3581: 3574: 3566: 3562: 3558: 3554: 3550: 3546: 3543:(6): 405–17. 3542: 3538: 3531: 3523: 3519: 3515: 3511: 3508:(2): 206–12. 3507: 3503: 3496: 3488: 3484: 3480: 3474: 3466: 3462: 3457: 3452: 3448: 3444: 3440: 3436: 3432: 3425: 3423: 3421: 3412: 3408: 3403: 3398: 3394: 3390: 3386: 3382: 3378: 3371: 3369: 3367: 3352: 3348: 3341: 3327: 3323: 3317: 3309: 3305: 3301: 3297: 3292: 3287: 3283: 3279: 3275: 3267: 3259: 3255: 3250: 3245: 3241: 3237: 3233: 3229: 3225: 3218: 3210: 3206: 3201: 3196: 3192: 3188: 3184: 3180: 3176: 3169: 3162: 3158: 3151: 3143: 3139: 3135: 3131: 3127: 3123: 3119: 3115: 3108: 3106: 3104: 3102: 3093: 3089: 3085: 3081: 3077: 3073: 3070:(4): 969–76. 3069: 3065: 3058: 3056: 3054: 3052: 3050: 3041: 3037: 3032: 3027: 3024:(6): 1453–6. 3023: 3019: 3015: 3008: 3000: 2996: 2991: 2986: 2982: 2978: 2974: 2970: 2966: 2962: 2958: 2951: 2949: 2947: 2931: 2927: 2921: 2919: 2917: 2915: 2906: 2902: 2897: 2892: 2887: 2882: 2878: 2874: 2870: 2863: 2855: 2851: 2847: 2843: 2839: 2835: 2831: 2827: 2820: 2818: 2809: 2805: 2800: 2795: 2791: 2787: 2783: 2779: 2775: 2768: 2766: 2758: 2753: 2745: 2741: 2737: 2733: 2728: 2723: 2719: 2715: 2711: 2704: 2696: 2692: 2687: 2682: 2678: 2674: 2670: 2666: 2665:EXCLI Journal 2659: 2652: 2644: 2640: 2635: 2630: 2625: 2620: 2616: 2612: 2608: 2601: 2599: 2597: 2588: 2584: 2579: 2574: 2570: 2566: 2563:(51): 1–238. 2562: 2558: 2557: 2552: 2545: 2543: 2541: 2532: 2528: 2523: 2518: 2514: 2510: 2507:(58): 1–406. 2506: 2502: 2501: 2496: 2489: 2481: 2477: 2472: 2467: 2463: 2459: 2454: 2449: 2445: 2441: 2437: 2430: 2428: 2426: 2417: 2413: 2409: 2405: 2402:(2): 502–26. 2401: 2397: 2389: 2387: 2378: 2374: 2368: 2360: 2356: 2352: 2348: 2344: 2340: 2337:(2): 141–50. 2336: 2332: 2325: 2317: 2313: 2308: 2303: 2298: 2293: 2289: 2285: 2281: 2274: 2266: 2262: 2258: 2254: 2250: 2246: 2242: 2238: 2230: 2222: 2218: 2214: 2210: 2205: 2200: 2196: 2192: 2189:(4): 340–50. 2188: 2184: 2177: 2170: 2162: 2158: 2154: 2150: 2146: 2142: 2138: 2134: 2127: 2119: 2115: 2111: 2107: 2103: 2099: 2095: 2091: 2087: 2083: 2076: 2074: 2065: 2061: 2057: 2053: 2049: 2045: 2041: 2037: 2030: 2022: 2018: 2014: 2010: 2006: 2002: 1998: 1994: 1987: 1979: 1975: 1970: 1965: 1961: 1957: 1953: 1946: 1938: 1934: 1930: 1926: 1922: 1918: 1911: 1903: 1899: 1894: 1889: 1885: 1881: 1877: 1870: 1868: 1859: 1855: 1851: 1847: 1843: 1839: 1835: 1831: 1824: 1816: 1812: 1808: 1804: 1801:(6): 1174–9. 1800: 1796: 1789: 1781: 1777: 1772: 1767: 1762: 1757: 1753: 1749: 1745: 1738: 1730: 1726: 1721: 1716: 1712: 1708: 1704: 1697: 1691: 1687: 1684: 1679: 1671: 1667: 1661: 1653: 1649: 1645: 1641: 1637: 1633: 1629: 1625: 1621: 1617: 1613: 1606: 1598: 1594: 1589: 1584: 1580: 1576: 1572: 1568: 1564: 1560: 1556: 1549: 1541: 1537: 1532: 1527: 1523: 1519: 1514: 1509: 1505: 1501: 1497: 1489: 1481: 1477: 1474:(6): 468–74. 1473: 1469: 1465: 1458: 1444:on 2014-01-04 1443: 1439: 1433: 1429: 1425: 1418: 1410: 1406: 1402: 1398: 1394: 1390: 1383: 1367: 1363: 1357: 1355: 1353: 1344: 1340: 1335: 1330: 1326: 1322: 1318: 1314: 1310: 1303: 1295: 1291: 1286: 1281: 1277: 1273: 1268: 1263: 1259: 1255: 1251: 1244: 1242: 1237: 1229: 1227: 1217: 1214: 1211: 1207: 1202: 1200: 1196: 1187: 1185: 1181: 1177: 1173: 1162: 1160: 1156: 1146: 1140: 1139: 1138: 1136: 1131: 1128: 1118: 1116: 1112: 1108: 1104: 1100: 1097:Prophylactic 1090: 1084: 1081: 1078: 1075: 1070: 1067: 1066: 1065: 1062: 1061: 1057: 1050: 1047: 1044: 1041: 1038: 1037: 1036: 1035: 1031: 1029: 1021: 1018: 1015: 1012: 1009: 1008: 1007: 1006: 1002: 991: 987: 983: 980: 976: 973: 969: 965: 964: 963: 959: 958: 957:Other cancers 954: 951: 947: 942: 941: 937: 934: 933:Colonoscopies 930: 929: 925: 923: 914: 912: 908: 904: 899: 897: 889: 885: 882: 879: 876: 875: 874: 872: 862: 860: 855: 851: 847: 843: 833: 831: 827: 818: 816: 812: 808: 804: 800: 796: 786: 782: 780: 775: 772: 763: 760: 757: 755: 754: 750: 747: 746: 743: 740: 737: 735: 734: 730: 727: 726: 722: 719: 716: 714: 713: 709: 706: 705: 701: 698: 695: 693: 692: 688: 685: 684: 680: 677: 674: 672: 671: 667: 664: 663: 659: 656: 653: 651: 650: 646: 643: 639: 638: 634: 631: 628: 626: 625: 620: 619: 615: 612: 608: 607: 603: 600: 597: 594: 591: 588: 587: 584: 582: 578: 569: 565: 562: 558: 554: 550: 549: 548: 547:to function: 546: 541: 539: 535: 531: 527: 523: 519: 515: 507: 502: 488: 485: 483: 482: 478: 477: 473: 470: 468: 467: 463: 462: 458: 455: 453: 452: 447: 446: 442: 441: 437: 434: 432: 431: 427: 426: 422: 419: 416: 415: 404: 401: 398: 395: 392: 389: 386: 384: 381: 380: 376: 373: 370: 367: 364: 361: 358: 356: 353: 352: 348: 345: 342: 339: 336: 333: 330: 328: 325: 324: 320: 317: 314: 311: 308: 305: 302: 299: 296: 293: 292: 289: 286: 283: 279: 274: 270: 266: 262: 258: 253: 251: 250:breast cancer 247: 243: 239: 235: 225: 222: 219: 218: 214: 211: 208: 207: 203: 200: 197: 196: 192: 189: 186: 185: 181: 178: 175: 174: 171: 170: 169: 154: 152: 147: 145: 141: 137: 133: 129: 128:urinary tract 125: 121: 117: 113: 109: 105: 101: 96: 94: 90: 86: 76: 70: 67: 65: 61: 57: 56:H&E stain 53: 49: 45: 41: 37: 33: 28: 23: 4909: 4860: 4781: 4776:Termination/ 4760: 4630: 4612: 4588: 4570: 4541: 4523: 4493: 4419: 4406: 4372: 4346:hyperplastic 4335: 4328:Colon/rectum 4120: 4079: 4068: 4044: 4033: 4016: 3997: 3978: 3930: 3903:. Retrieved 3901:. 2018-03-20 3893: 3881:. Retrieved 3872: 3860:. Retrieved 3851: 3843:the original 3822: 3818: 3808: 3776:(4): 261–8. 3773: 3769: 3759: 3734: 3730: 3720: 3685: 3681: 3671: 3636: 3632: 3622: 3587: 3583: 3573: 3540: 3536: 3530: 3505: 3501: 3495: 3487:the original 3482: 3473: 3438: 3434: 3384: 3380: 3354:. Retrieved 3350: 3340: 3329:. Retrieved 3325: 3316: 3281: 3277: 3266: 3231: 3227: 3217: 3185:(1): 41–52. 3182: 3178: 3168: 3150: 3117: 3113: 3067: 3063: 3021: 3017: 3007: 2964: 2960: 2934:. Retrieved 2932:. 2020-04-01 2929: 2876: 2872: 2862: 2829: 2825: 2781: 2777: 2752: 2717: 2713: 2703: 2668: 2664: 2651: 2617:(10): 1567. 2614: 2610: 2560: 2554: 2504: 2498: 2488: 2443: 2439: 2399: 2395: 2377:the original 2367: 2334: 2330: 2324: 2290:(2): 103–4. 2287: 2283: 2273: 2240: 2236: 2229: 2186: 2182: 2169: 2136: 2132: 2126: 2085: 2081: 2042:(3): 271–2. 2039: 2035: 2029: 1996: 1992: 1986: 1959: 1955: 1945: 1920: 1916: 1910: 1883: 1879: 1833: 1829: 1823: 1798: 1794: 1788: 1751: 1747: 1737: 1710: 1706: 1696: 1678: 1669: 1660: 1619: 1615: 1605: 1562: 1558: 1548: 1503: 1499: 1488: 1471: 1467: 1457: 1446:. Retrieved 1442:the original 1427: 1417: 1392: 1388: 1382: 1372:November 18, 1370:. Retrieved 1365: 1316: 1312: 1302: 1257: 1253: 1223: 1215: 1203: 1193: 1168: 1165:Epidemiology 1152: 1144: 1132: 1124: 1099:hysterectomy 1096: 1088: 1063: 1059: 1058: 1054: 1033: 1032: 1025: 1004: 1003: 1000: 960: 956: 955: 943: 939: 938: 931: 928:Colon cancer 927: 926: 920: 906: 902: 900: 893: 868: 839: 824: 792: 783: 776: 770: 769:People with 768: 751: 738:case report 731: 717:case report 710: 689: 681:Miyaki 1997 668: 647: 635:Fishel 1993 622: 616: 573: 553:DNA helicase 542: 511: 479: 464: 449: 443: 428: 382: 354: 326: 287: 265:constipation 254: 231: 198:Endometrial 167: 166: 165: 148: 99: 97: 93:colon cancer 88: 84: 83: 4881:MRN complex 4590:gallbladder 4543:hyperplasia 4070:GeneReviews 3326:www.bbc.com 2930:www.cdc.gov 2879:(7): 1874. 2720:: 136–157. 2671:: 159–168. 2139:(1): 17–8. 1506:(10): 786. 1500:Diagnostics 1190:Terminology 1028:endometrium 972:small bowel 859:immunoscore 559:(RPA), and 538:nucleobases 269:weight loss 187:Colorectal 4967:Categories 4801:DNA repair 4778:telomerase 4676:Peritoneum 4046:DiseasesDB 3949:1089450897 3479:"Oncolink" 3356:2024-09-18 3331:2024-09-18 2936:2020-12-07 2446:(3): 391. 1754:(1): 576. 1748:BMC Cancer 1448:2014-06-23 1232:References 1176:Icelanders 813:(IHC), or 40:Micrograph 4635:neoplasms 4572:bile duct 4495:malignant 4477:Accessory 4407:Neoplasm: 4390:Gardner's 4313:Carcinoid 4199:Esophagus 4133:GeneTests 4109:from the 3308:227259533 2981:0017-5749 2744:252289107 2462:2072-6694 1858:195795805 1636:1097-6868 1579:1468-3288 1522:2075-4418 1276:1007-9327 1127:colectomy 1121:Treatment 917:Screening 896:histology 789:Diagnosis 758:disputed 720:2q31-q33 640:HNPCC2 ( 609:HNPCC1 ( 583:pathway: 530:pathology 64:Specialty 4762:RNASEH2A 4605:Pancreas 4376:Juvenile 4350:juvenile 4305:Appendix 4181:GI tract 4103:Archived 4081:Orphanet 3905:31 March 3883:31 March 3862:31 March 3839:15611508 3800:14970275 3751:16253017 3712:11112663 3663:15855431 3614:19793571 3565:25600795 3557:19851131 3465:30627969 3411:29485237 3300:33264544 3258:26028255 3209:17636426 3161:31378807 3142:32833106 3134:27990589 3084:26602911 3040:10348829 2999:23408351 2905:32664613 2854:29024566 2846:28411145 2808:31780574 2736:36115290 2695:29743854 2643:31618962 2587:28895526 2531:25244061 2480:33494280 2416:25043945 2359:25479413 2351:19851887 2316:19804606 2265:10608978 2257:18625694 2221:15526044 2213:19156873 2161:46658147 2064:22473295 1978:29447627 1937:30231390 1850:31273487 1815:12637487 1780:29783979 1729:10321739 1707:Oncogene 1686:Archived 1652:29024566 1644:28411145 1597:28754778 1540:33027913 1480:26977831 1409:28891842 1343:19861671 1294:26309352 1149:Research 761:14q24.3 508:fashion. 496:Genetics 261:diarrhea 220:Ovarian 209:Gastric 126:, upper 69:Oncology 42:showing 4342:adenoma 4222:Stomach 4040:D003123 3791:2933058 3703:1234904 3654:2933042 3605:3454516 3522:5901552 3456:6450737 3402:5980692 3249:4481136 3200:2847875 3092:6014333 2990:3647358 2896:7408795 2873:Cancers 2799:7034349 2686:5938532 2634:6826728 2611:Cancers 2578:5611555 2522:4781313 2471:7864494 2440:Cancers 2307:2735474 2153:9590282 2118:4244907 2110:8072530 2090:Bibcode 2056:9354786 2021:8128251 2001:Bibcode 1993:Science 1902:8252616 1771:5963021 1588:6031262 1531:7600989 1366:DynaMed 1334:4091624 1285:4541378 1220:Society 1115:ovaries 1093:Surgery 968:stomach 748:HNPCC7 728:HNPCC6 707:HNPCC3 686:HNPCC4 665:HNPCC5 536:of the 474:16-26% 459:25-60% 438:25-60% 116:stomach 4632:cystic 4525:benign 4029:114400 4026:609310 4023:120435 3947:  3937:  3837:  3798:  3788:  3749:  3710:  3700:  3661:  3651:  3612:  3602:  3563:  3555:  3520:  3463:  3453:  3409:  3399:  3306:  3298:  3256:  3246:  3207:  3197:  3159:  3140:  3132:  3090:  3082:  3038:  2997:  2987:  2979:  2903:  2893:  2852:  2844:  2806:  2796:  2742:  2734:  2693:  2683:  2641:  2631:  2585:  2575:  2529:  2519:  2478:  2468:  2460:  2414:  2357:  2349:  2314:  2304:  2263:  2255:  2219:  2211:  2159:  2151:  2116:  2108:  2082:Nature 2062:  2054:  2019:  1976:  1962:(11). 1935:  1900:  1856:  1848:  1813:  1778:  1768:  1727:  1650:  1642:  1634:  1595:  1585:  1577:  1538:  1528:  1520:  1478:  1434:  1407:  1341:  1331:  1292:  1282:  1274:  1182:, and 1113:, and 1107:uterus 733:TGFBR2 675:7-10% 642:609310 611:120435 601:Locus 545:dimers 526:cancer 471:1-11% 456:4-24% 435:4-24% 204:48-62 201:25-60 193:44-61 190:52-58 134:, and 71:  46:(in a 4903:Other 4486:Liver 4271:Lower 4190:Upper 4122:hnpcc 4012:154.1 4008:153.0 3923:Books 3561:S2CID 3304:S2CID 3138:S2CID 3088:S2CID 2850:S2CID 2740:S2CID 2661:(PDF) 2355:S2CID 2261:S2CID 2217:S2CID 2179:(PDF) 2157:S2CID 2114:S2CID 2060:S2CID 1854:S2CID 1648:S2CID 990:brain 890:(TIL) 803:EPCAM 741:3p22 699:7p22 678:2p16 657:3p21 632:2p22 624:EPCAM 592:name 577:genes 451:EPCAM 417:Gene 377:n.a. 318:risk 306:risk 294:Gene 226:42.5 223:4-12 212:6-13 132:brain 112:ovary 102:, an 89:HNPCC 4783:DKC1 4742:and 4430:Anus 4051:5812 4035:MeSH 4018:OMIM 4003:9-CM 3945:OCLC 3935:ISBN 3907:2018 3885:2018 3864:2018 3835:PMID 3796:PMID 3747:PMID 3708:PMID 3659:PMID 3633:JAMA 3610:PMID 3553:PMID 3518:PMID 3461:PMID 3407:PMID 3296:PMID 3254:PMID 3205:PMID 3157:PMID 3130:PMID 3080:PMID 3036:PMID 2995:PMID 2977:ISSN 2901:PMID 2842:PMID 2804:PMID 2732:PMID 2691:PMID 2639:PMID 2583:PMID 2527:PMID 2476:PMID 2458:ISSN 2412:PMID 2347:PMID 2312:PMID 2253:PMID 2209:PMID 2149:PMID 2106:PMID 2052:PMID 2017:PMID 1974:PMID 1933:PMID 1898:PMID 1880:Cell 1846:PMID 1811:PMID 1776:PMID 1725:PMID 1640:PMID 1632:ISSN 1593:PMID 1575:ISSN 1536:PMID 1518:ISSN 1476:PMID 1432:ISBN 1405:PMID 1374:2019 1339:PMID 1313:JAMA 1290:PMID 1272:ISSN 1101:and 970:and 771:MSH6 753:MLH3 712:PMS1 691:PMS2 670:MSH6 649:MLH1 618:MSH2 590:OMIM 489:15% 481:PMS2 466:MSH6 445:MSH2 430:MLH1 402:18% 399:11% 393:13% 390:46% 387:15% 383:MSH6 371:32% 368:25% 365:10% 362:17% 359:57% 355:MSH2 346:17% 340:21% 337:10% 334:43% 331:46% 327:MLH1 248:and 136:skin 4849:MSI 4127:NIH 4125:at 4086:144 3999:ICD 3993:C20 3989:C18 3980:ICD 3827:doi 3786:PMC 3778:doi 3739:doi 3735:129 3698:PMC 3690:doi 3649:PMC 3641:doi 3637:293 3600:PMC 3592:doi 3545:doi 3510:doi 3506:117 3451:PMC 3443:doi 3397:PMC 3389:doi 3286:doi 3282:383 3244:PMC 3236:doi 3232:372 3195:PMC 3187:doi 3122:doi 3072:doi 3026:doi 3022:116 2985:PMC 2969:doi 2961:Gut 2891:PMC 2881:doi 2834:doi 2830:217 2794:PMC 2786:doi 2778:Gut 2722:doi 2718:175 2681:PMC 2673:doi 2629:PMC 2619:doi 2573:PMC 2565:doi 2517:PMC 2509:doi 2466:PMC 2448:doi 2404:doi 2400:147 2339:doi 2302:PMC 2292:doi 2245:doi 2237:Gut 2199:hdl 2191:doi 2141:doi 2098:doi 2086:371 2044:doi 2009:doi 1997:263 1964:doi 1925:doi 1888:doi 1838:doi 1803:doi 1766:PMC 1756:doi 1715:doi 1624:doi 1620:217 1583:PMC 1567:doi 1559:Gut 1526:PMC 1508:doi 1397:doi 1329:PMC 1321:doi 1317:302 1280:PMC 1262:doi 913:). 854:PCR 846:MSI 799:MMR 405:1% 396:7% 374:5% 349:1% 343:8% 263:or 215:56 52:MSI 4969:: 4780:: 4738:: 4638:: 4364:, 4360:, 4356:, 4352:, 4348:, 4344:, 4131:UW 4084:: 4073:: 4049:: 4038:: 4021:: 4006:: 3987:: 3984:10 3943:. 3833:. 3823:22 3821:. 3817:. 3794:. 3784:. 3774:96 3772:. 3768:. 3745:. 3733:. 3729:. 3706:. 3696:. 3686:68 3684:. 3680:. 3657:. 3647:. 3635:. 3631:. 3608:. 3598:. 3588:18 3586:. 3582:. 3559:. 3551:. 3541:16 3539:. 3516:. 3504:. 3481:. 3459:. 3449:. 3439:18 3437:. 3433:. 3419:^ 3405:. 3395:. 3385:68 3383:. 3379:. 3365:^ 3349:. 3324:. 3302:. 3294:. 3280:. 3276:. 3252:. 3242:. 3230:. 3226:. 3203:. 3193:. 3181:. 3177:. 3136:. 3128:. 3118:62 3116:. 3100:^ 3086:. 3078:. 3068:61 3066:. 3048:^ 3034:. 3020:. 3016:. 2993:. 2983:. 2975:. 2965:62 2963:. 2959:. 2945:^ 2928:. 2913:^ 2899:. 2889:. 2877:12 2875:. 2871:. 2848:. 2840:. 2828:. 2816:^ 2802:. 2792:. 2782:69 2780:. 2776:. 2764:^ 2738:. 2730:. 2716:. 2712:. 2689:. 2679:. 2669:17 2667:. 2663:. 2637:. 2627:. 2615:11 2613:. 2609:. 2595:^ 2581:. 2571:. 2561:21 2559:. 2553:. 2539:^ 2525:. 2515:. 2505:18 2503:. 2497:. 2474:. 2464:. 2456:. 2444:13 2442:. 2438:. 2424:^ 2410:. 2398:. 2385:^ 2353:. 2345:. 2333:. 2310:. 2300:. 2286:. 2282:. 2259:. 2251:. 2241:57 2239:. 2215:. 2207:. 2197:. 2187:48 2185:. 2181:. 2155:. 2147:. 2137:19 2135:. 2112:. 2104:. 2096:. 2084:. 2072:^ 2058:. 2050:. 2040:17 2038:. 2015:. 2007:. 1995:. 1972:. 1960:23 1958:. 1954:. 1931:. 1921:38 1919:. 1896:. 1884:75 1882:. 1878:. 1866:^ 1852:. 1844:. 1834:24 1832:. 1809:. 1799:21 1797:. 1774:. 1764:. 1752:18 1750:. 1746:. 1723:. 1711:18 1709:. 1705:. 1668:. 1646:. 1638:. 1630:. 1618:. 1614:. 1591:. 1581:. 1573:. 1563:67 1561:. 1557:. 1534:. 1524:. 1516:. 1504:10 1502:. 1498:. 1472:93 1470:. 1466:. 1426:. 1403:. 1393:60 1391:. 1364:. 1351:^ 1337:. 1327:. 1315:. 1311:. 1288:. 1278:. 1270:. 1258:21 1256:. 1252:. 1240:^ 1178:, 1174:, 1109:, 944:A 644:) 613:) 555:, 146:. 130:, 122:, 118:, 114:, 95:. 4929:/ 4851:/ 4820:/ 4728:e 4721:t 4714:v 4616:: 4592:: 4574:: 4545:: 4527:: 4497:: 4388:/ 4339:: 4165:e 4158:t 4151:v 4129:/ 4010:- 4001:- 3991:- 3982:- 3972:D 3951:. 3909:. 3887:. 3866:. 3829:: 3802:. 3780:: 3753:. 3741:: 3714:. 3692:: 3665:. 3643:: 3616:. 3594:: 3567:. 3547:: 3524:. 3512:: 3467:. 3445:: 3413:. 3391:: 3359:. 3334:. 3310:. 3288:: 3260:. 3238:: 3211:. 3189:: 3183:7 3163:. 3144:. 3124:: 3094:. 3074:: 3042:. 3028:: 3001:. 2971:: 2939:. 2907:. 2883:: 2856:. 2836:: 2810:. 2788:: 2746:. 2724:: 2697:. 2675:: 2645:. 2621:: 2589:. 2567:: 2533:. 2511:: 2482:. 2450:: 2418:. 2406:: 2361:. 2341:: 2335:9 2318:. 2294:: 2288:6 2267:. 2247:: 2223:. 2201:: 2193:: 2163:. 2143:: 2120:. 2100:: 2092:: 2066:. 2046:: 2023:. 2011:: 2003:: 1980:. 1966:: 1939:. 1927:: 1904:. 1890:: 1860:. 1840:: 1817:. 1805:: 1782:. 1758:: 1731:. 1717:: 1672:. 1654:. 1626:: 1599:. 1569:: 1542:. 1510:: 1482:. 1451:. 1411:. 1399:: 1376:. 1345:. 1323:: 1296:. 1264:: 1076:) 988:( 621:/ 563:. 448:/ 87:( 58:.

Index


Micrograph
tumor-infiltrating lymphocytes
colorectal cancer
MSI
H&E stain
Specialty
Oncology
Edit this on Wikidata
colon cancer
autosomal dominant
endometrial cancer
ovary
stomach
small intestine
hepatobiliary tract
urinary tract
brain
skin
DNA mismatch repair
cancer syndrome
polymerase proofreading-associated polyposis
pancreatic cancer
biliary tract cancer
sebaceous neoplasms
prostate cancer
breast cancer
proximal colon
diarrhea
constipation

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑